phosphatidylcholines has been researched along with alprostadil in 17 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 7,136 | 864 | 761 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borek, C; Lowenstein, JM; Ong, A; Przetakiewicz, M; Takahashi, M | 1 |
| Iaĭlenko, TL; Ianopol'skaia, ND; Sorokina, AD; Vibas, IM; Voguslavskiĭ, LI | 1 |
| Bajci, A; Davidovskaya, TL; Hianik, T; Laputková, G | 1 |
| Boguslavskiĭ, LI; Freĭmanis, Ia; Iaĭlenko, TL; Sokolov, GP; Sorokina, AD | 1 |
| Anwer, K; Romstedt, K; Wallace, D | 1 |
| Butcher, RW; Clark, RB; Proll, MA | 1 |
| Bergel'son, LD; Korobkova, EN; Muzia, GI | 1 |
| Bergelson, LD; Golovanova, NK; Korobkova, EN; Muzya, GI | 1 |
| Aikawa, M; Sakagami, T; Taniguchi, M | 1 |
| Girault, M; Pocidalo, JJ; Syrota, A; Yudilevich, DL | 1 |
| Badzhinian, SA; Gabrielian, ES | 1 |
| Mizushima, Y; Yamaguchi, T | 1 |
| Eierman, DF; Erme, SM; Harmon, PA; Janoff, AS; Minchey, SR; Pratt, KJ; Yagami, M | 1 |
| Härmälä, AS; Jansson, C; Slotte, JP; Toivola, DM | 1 |
| Bakogianni, M; Baschali, A; Kalofoutis, A; Papapanagiotoy, A | 1 |
| Karmel, J; McGaw, J; Rigby, AS; Taylor, CJ; Threlfall, D | 1 |
| Berliner, JA; Cruz, D; Dun, M; Gharavi, N; Koroniak, L; Li, R; Montoya, D; Mouillesseaux, KP | 1 |
1 review(s) available for phosphatidylcholines and alprostadil
| Article | Year |
|---|---|
Lipid microspheres for drug delivery from the pharmaceutical viewpoint.
Topics: Adsorption; Alprostadil; Biological Availability; Dexamethasone; Drug Delivery Systems; Emulsions; Flurbiprofen; Humans; Lipids; Microspheres; Particle Size; Phosphatidylcholines; Soybean Oil | 1994 |
1 trial(s) available for phosphatidylcholines and alprostadil
| Article | Year |
|---|---|
Pilot safety study of liposomal prostaglandin (PGE1) in respiratory exacerbations in cystic fibrosis.
Topics: Adolescent; Alprostadil; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cystic Fibrosis; Double-Blind Method; Humans; Infusions, Intravenous; Liposomes; Lung Diseases; Phosphatidylcholines; Pilot Projects; Pseudomonas Infections; Respiratory Function Tests; Sputum; Treatment Outcome | 2002 |
15 other study(ies) available for phosphatidylcholines and alprostadil
| Article | Year |
|---|---|
Effect of omega 3 and omega 6 fatty acids on transformation of cultured cells by irradiation and transfection.
Topics: 3T3 Cells; Alprostadil; Animals; Arachidonic Acid; Cell Transformation, Neoplastic; Dinoprostone; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Fibroblasts; Genes, ras; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Time Factors; Transfection | 1992 |
[Study of the dependence of the permeability of phosphatidylcholine liposomes for glucose on their prostaglandin level].
Topics: Alprostadil; Glucose; Liposomes; Permeability; Phosphatidylcholines | 1991 |
Prostaglandin E1 induced changes in conductivity of lipid bilayers.
Topics: Alprostadil; Electric Conductivity; Gramicidin; Kinetics; Lipid Bilayers; Membrane Potentials; Models, Theoretical; Muscle, Smooth; Phosphatidylcholines | 1986 |
[Proton permeability of liposomes caused by the interaction between phosphatidylcholine and prostaglandin E1 and its analog].
Topics: Alprostadil; Liposomes; Permeability; Phosphatidylcholines; Prostaglandins E, Synthetic; Protons; Spectrophotometry, Ultraviolet | 1988 |
Human platelet activation by bacterial phospholipase C: mechanism of inhibition by flurazepam.
Topics: Alprostadil; Biomechanical Phenomena; Blood Platelets; Blood Proteins; Clostridium perfringens; Diglycerides; Ethers; Flurazepam; Humans; Hydrolysis; Ionomycin; Phosphatidylcholines; Phosphoproteins; Phosphorylation; Platelet Aggregation; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1988 |
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Alprostadil; Carbachol; Cell Line; Cell Membrane; Cyclic AMP; Diglycerides; GTP-Binding Proteins; Humans; Lysophospholipids; Magnesium; Pertussis Toxin; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Platelet Activating Factor; Virulence Factors, Bordetella | 1985 |
[Effect of prostaglandins on lipid transfer between high- and low-density lipoproteins in human plasma].
Topics: Alprostadil; Biological Transport; Cholesterol Esters; Humans; In Vitro Techniques; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Phosphatidylcholines; Stimulation, Chemical | 1988 |
Influence of prostaglandins on the lipid transfer between human high density and low density lipoproteins.
Topics: Alprostadil; Carrier Proteins; Cholesterol Esters; Dinoprost; Dinoprostone; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Phosphatidylcholines; Prostaglandins; Prostaglandins E; Prostaglandins F | 1987 |
Comparative studies on hemolysis in the erythrocytes from various animals: inhibitory effect of prostaglandins and phospholipid content.
Topics: Adult; Alprostadil; Animals; Cattle; Dinoprostone; Erythrocytes; Hemolysis; Humans; Hypotonic Solutions; Male; Phosphatidylcholines; Phospholipids; Prostaglandins E; Rabbits; Rats; Species Specificity; Sphingomyelins; Superoxides; Swine | 1982 |
Endothelial uptake of amino acids, sugars, lipids, and prostaglandins in rat lung.
Topics: Alprostadil; Amino Acids; Animals; Arachidonic Acid; Arachidonic Acids; Biological Transport; Cholesterol; Endothelium; Fatty Acids, Nonesterified; Hexoses; Kinetics; Lung; Male; Phosphatidylcholines; Prostaglandins E; Rats; Rats, Inbred Strains | 1982 |
[Effect of prostaglandins on the conductivity of model membranes].
Topics: Alprostadil; Calcium; Dinoprost; Epoprostenol; Gangliosides; Lipid Bilayers; Permeability; Phosphatidylcholines; Potassium; Prostaglandins; Prostaglandins E; Prostaglandins F | 1981 |
Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.
Topics: Alprostadil; Animals; CD11 Antigens; CD18 Antigens; Cyclic AMP; Disease Models, Animal; Escherichia coli; Flow Cytometry; Humans; Lipopolysaccharides; Liposomes; Lymphocytes; Male; Monocytes; Neutrophils; Opsonin Proteins; Phagocytosis; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Toxemia | 1995 |
Effects of the phospholipid environment in the plasma membrane on receptor interaction with the adenylyl cyclase complex of intact cells.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Cell Line; Cell Membrane; Cholesterol; Colforsin; Cricetinae; Cricetulus; Enzyme Activation; Humans; Phosphatidylcholines; Phospholipids; Receptors, Adrenergic, alpha; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Sphingomyelins | 1993 |
Effects of prostaglandin E1 on high density lipoprotein-phospholipid composition.
Topics: Alprostadil; Animals; Diglycerides; Lipoproteins, HDL; Lysophosphatidylcholines; Phosphatidylcholines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Rats; Rats, Wistar | 1999 |
Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC.
Topics: Alprostadil; Atherosclerosis; Cells, Cultured; Dinoprostone; Foam Cells; Humans; Interleukin-10; Isoprostanes; Macrophages; Monocytes; Oxidation-Reduction; Phosphatidylcholines; Phospholipid Ethers; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthones | 2006 |